
Episode 128: Debate of the Decade: RCTs in the Era of Precision Oncology
Healthcare Unfiltered
00:00
The Importance of Randomized Controlled Trials
Vivek: Let's run an RCT first line pancreas. I would go on that study if I was a patient. Chris: Clinical trials do not reflect the real world. 90 to 95% of patients are not eligible for a clinical trial. Vivek: If we see dramatic benefits and we see it in real world type patients, I don't think we should be doing a randomized trial at that point.
Play episode from 01:12:07
Transcript


